Polymerase Chain Reaction Market – Insights
Polymerase chain reaction (PCR) is extensively used for DNA amplification technique. It generates thousands to millions of copies of a particular DNA sequence. The PCR industry is shifting its focus away from macro-scale systems and is focused on developing the micro-scale devices. Micro-scale devices offer various benefits such as micro-scale sample sizes requires less blood from patients, it takes less reaction time and also offers cost-effective benefits, as many microfluidic devices are manufactured from inexpensive polymers. Increasing adoption of polymerase chain reaction in various diagnostic and research application, growing research and development funding in gene therapy, and continuous technological advancement in polymerase chain reaction are projected to augment growth of the market over the forecast period.
The global polymerase chain reaction market was valued at US$ 3.7 billion in 2017 and is expected to witness a CAGR of 8.8% over the forecast period (2017 – 2025).
Global Polymerase Chain Reaction Market Share (%), By Product Type
Source: Coherent Market Insights Analysis (2018)
Increasing Numbers of Product Launches and Collaborations in Polymerase Chain Reaction are expected to Drive Growth of the Polymerase Chain Reaction Market
Key players in the polymerase chain reaction market are engaged in launching advanced and novel PCR instruments and consumables, which will allows rapid and easy nucleic acid amplification. For instance, in October 2017, Diatech Pharmacogenetics srl launched easyPGX: a ready to use in-vitro diagnostic real-time PCR product line and Helix: a polymerase chain reaction kit for the extraction of circulating free DNA from plasma. In September 2015, Bio-Rad Laboratories launched droplet digital PCR (ddPCR) Supermix for Residual DNA Quantification. The new supermix designed to use with Bio-Rad’s Droplet Digital PCR Systems offers highly precise and sensitive method for DNA measurement. In November 2014, Chai Biotechnologies Inc. introduced Open qPCR: Real-Time PCR Thermocycler. The new instrument is designed to use for genetic genotyping, pathogen detection, and relative DNA quantification. Moreover, in April 2014, Bio-Rad Laboratories launched Precision Blue Real-Time PCR Dye. The new Precision Blue dye is compatible with Bio-Rad’s universal qPCR supermixes, and can be used with all Bio-Rad’s CFx real time PCR systems.
Furthermore, key players are involved in several collaborations to expand their geographical horizon and increase patient reach. For instance, in March 2018, Akonni Biosystems Inc. and a Chinese in-vitro diagnostics company: Righton signed a commercial agreement, which enables Righton to sell Akonni's TruDiagnosis and TruTip Nucleic Acid Purification Kits in China. TruDiagnosis is based on proprietary on-slide PCR and gel-drop microarray technology. In January 2018, Thermo Fisher Scientific and Illumina, Inc. signed a commercial agreement. Under the agreement, Thermo Fisher will provide Ion AmpliSeq technology to Illumina for research purpose. Moreover, in December 2017, Genome Diagnostics (GenDx) signed a global reseller agreement with Thermo Fisher Scientific, assigning GenDx as a non-exclusive reseller of Thermo Fisher’s QuantStudio real-time PCR instrument. Under the agreement, GenDx will market the QuantStudio real-time PCR in the Netherlands and other European countries. Thus, significant organic and inorganic growth strategies by various key players is driving growth of the polymerase chain reaction market.
Increasing Prevalence of Chronic and Infectious Disease are Driving Growth of Polymerase Chain Reaction Market
Polymerase chain reaction is increasingly used in clinical diagnosis of infectious disease, nucleic acid amplification, paternity testing, DNA fingerprinting, detection and diagnosis of infectious disease, quality control, and personalized medicine. For instance, according to the Centers for Disease Control and Prevention (CDC), around 5,251 deaths due to the influenza infection were registered in 2015, in U.S. According to the World Health Organization (WHO), in 2015, around 32,000 estimated deaths were reported from tuberculosis and around 3, 23,000 new cases of TB cases were registered in the European region. According to the National Ambulatory Medical Care Survey: 2015 data findings, 16.8 million visits to physician offices for infectious and parasitic diseases were registered in the U.S. According to the World Health Organization (WHO), 2016, around 555,318 new cases of cancer were reported in 2012, in the Middle East Region. The region is expected to witness the highest relative increase of cancer cases among the regions in the world accounting to 961,098 cases by 2030. Moreover, according to the Cancer Atlas, 2012, about 1.1 million new cancer cases and 600,000 cancer deaths occurred annually in Latin America and the Caribbean, where lung cancer is the leading cause of cancer death for both genders combined in the region.
However, advances in research are leading to generation of various alternative nucleic acid amplification methods, which may hinder growth of the polymerase chain reaction market over the forecasted period. Such alternative methods of nucleic acid amplification includes loop medicated isothermal amplification, nucleic acid sequence based amplification, strand displacement amplification, and multiple displacement amplification. These methods offers better applicability and sensitivity in nucleic acid amplification, where PCR shows limitations such as contamination, sensitivity to certain classes of contaminants and inhibitors, and requirement of thermal cycling. Key players in the polymerase chain reaction are engaged in offering PCR-free nucleic acid detection methods. For instance, in March 2018, Quanterix Corporation and DestiNA Genomics collaborated to develop PCR-free microRNA detection method with high-specificity and ultra-sensitivity, thereby enhancing RNA biomarker detection.
Key players operating in polymerase chain reaction market include F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., bioMérieux, S.A., Enzo Life Science, Inc., Abbott Laboratories, Takara Bio Inc., Becton, Dickinson and Company, and Danaher Corporation.
Polymerase chain reaction (PCR) is used to amplify a specific segment of DNA through a thermal cycling protocol. Continuous technological advancement in the field of polymerase chain reaction are aimed to improve specificity, scalability and reliability in DNA amplification and thereby creating millions of amplicons of a target sequence in a short period of time. PCR is used for various applications, including the detection of pathogenic bacteria, disease diagnosis, molecular and genetic research, forensic DNA profiling, and parental testing. Rapid technological advancement in the polymerase chain reaction to deliver highly sensitive and optimized detection instrument, increasing prevalence of chronic and infectious disease, and growing research funding in gene therapy and molecular testing is projected to drive growth of the polymerase chain reaction market over the forecast period.
The global polymerase chain reaction market is projected to witness significant growth over the forecast period, owing to its wide and increasing applications in various fields, which include diagnosis of infectious diseases, such as middle ear infections, tuberculosis, Lyme disease, in forensics, including DNA fingerprinting, paternity testing and in various other molecular research applications, such as DNA sequencing, DNA cloning, and gene expression. Polymerase chain reaction is used for diagnosis of genetic disease, allowing to detect inherited genetic change or spontaneous genetic mutation.
PCR is used in personalized medicine to help patients in selecting certain treatments, such as in cancer when patients have a genetic change that makes a patient more or less likely to respond to a certain treatment. Polymerase chain reaction is used to study the molecular characteristics in cancer patients, in order to deliver tailored cancer therapy in lung and colorectal cancer. Real-time PCR offers higher sensitivity and specificity in various range of nucleic acid amplification, which is used in wide research areas including infectious disease research, translational medicine to applied biology. Furthermore, technological advancement in the PCR reagents, assay, instruments and analysis tools, help to provide more customized results in various research areas, such as stem cell research, oncology and genetic disease research, pharmaceutical analytics, pharmacogenomics, plant science research and agriculture biotechnology. Such wide numbers of PCR applications in the different field of healthcare and medical research areas, are estimated to augment growth of the polymerase chain reaction market over the forecast period.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
*Browse 28 market data tables and 34 figures on "Polymerase Chain Reaction Market - Global forecast to 2025”.
Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:
In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.
Coherent Market Insights desk research is based on a principle set of research techniques:
Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:
Preliminary Data Mining
The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.
Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.
Coherent Statistical model
We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:
Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.
This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:
The primary research is conducted with the ecosystem players including, but not limited to:
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.